Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger

Azithromycin mass drug administration decreases child mortality but also selects for antibiotic resistance. Herein, we evaluate macrolide resistance of nasopharyngeal Streptococcus pneumoniae after azithromycin MDA. In a cluster-randomized trial, children 1–59 months received azithromycin or placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hazel, Ashley, Arzika, Ahmed M., Abdou, Amza, Lebas, Elodie, Porco, Travis C., Maliki, Ramatou, Doan, Thuy, Lietman, Thomas M., Keenan, Jeremy D., Blumberg, Seth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622462/
https://www.ncbi.nlm.nih.gov/pubmed/37783458
http://dx.doi.org/10.4269/ajtmh.23-0431

Ejemplares similares

Ejemplares similares